JPM Healthcare Week 2024

Conferences
Written By Michael Abrahamson

What a week at JP Morgan Healthcare! Met amazing investors and service providers, fueling Reglagene's journey in developing innovative brain therapies. The hard work of follow-ups begins, but we're more energized than ever! Big thanks to all for the inspiring discussions. Exciting updates ahead!
#JPMorganHealthcareWeek #Reglagene #HealthcareInnovation

Michael Abrahamson
Previous

Reglagene receives FDA Orphan Drug Designation for innovative brain cancer treatment
Next

Reglagene, Inc. announces closing of $5.4 million private placement